The IDI

Valuate Health Consultancy
  • 5.0 (3)
  • LIFE SCIENCES
  • UPDATED MONTHLY
The IDI

The IDI is a podcast by and for market access professionals. Each episode, we conduct in-depth interviews to get payer insights that help you optimize your value strategy and commercialization – and give people access to the heath care they deserve. The IDI is presented by Valuate Health Consultancy. Follow Valuate on LinkedIn or visit us at ValuateHealth.com to learn more.

  1. MAY 1

    Message Testing and Market Access

    Alex Mindlin, a Principal, with Valuate Health joins The IDI host Ira Apfel to explain message testing and market access -- why it's important for pharma and how to improve it.

    25 min

  2. APR 1

    Social Determinants of Health and Market Access

    Elisa Remoundos, Senior Vice President and Group Creative Director for Entrée Health, discusses social determinants of health and market access.

    25 min

  3. MAR 4

    A Payer’s Perspective on Prior Authorization

    Our recent episode about prior authorization was one of our most popular episodes so, to continue the conversation, we invited a payer executive, Dr. Andrew Hertler, on to the podcast get his perspective. Hertler is Chief Medical Officer at Evolent Health. Hertler recently co-authored an op-ed about prior authorization. In it, he touched on gold-carding, a controversial solution to addressing prior authorization challenges.

    36 min

  4. JAN 31

    What Do Payers Think About Market Access?

    To better understand payer perceptions of pharmaceutical manufacturers, Valuate conducted its Second Annual Market Access Survey -- and the results are eye-opening. Tony Gibson returns to The IDI to break down all of the results.

    27 min

  5. JAN 3

    Is Hub Optimization the Key for Drug Launches?

    Justine Hughes of Archbow Consulting explains why hub implementation is the key to a successful drug launch for pharma and market access. Hughes has led hub implementations for years so she's got some great advice -- and some amazing stories to tell.

    27 min

  6. 12/01/2023

    Politics and Prescription Drugs: What's Ahead in 2024

    2024 is just a month away; what will the new year hold for pharma and market access? Everything is up for grabs -- from the fate of the Inflation Reduction Act to the White House. Al Jackson of Valuate joins the IDI to explain what's a stake.

    31 min

  7. 10/12/2023

    Fighting Breast Cancer is Not a Solitary Struggle

    October is Breast Cancer Awareness Month, so to honor all breast cancer survivors, The IDI is doing something a little different this episode. Instead of our usual discussion of strategies and tactics to improve market access and commercialization, we invited Cora Meese of Entree Health to share her story about her breast cancer diagnosis and recovery journey.

    28 min

  8. 10/02/2023

    Why Prior Authorization Matters for Pharma

    Prior authorizations are a frustrating hurdle for patients who often need immediate treatment – including those in need of prescription drugs. Guests John Hennessy of Valuate and Syam Palakurthy of SamaCare join The IDI to explain the current state of prior authorization – and what’s at stake for pharma and market access.

    31 min
See All (26)

Ratings & Reviews

5
out of 5
3 Ratings

About

The IDI is a podcast by and for market access professionals. Each episode, we conduct in-depth interviews to get payer insights that help you optimize your value strategy and commercialization – and give people access to the heath care they deserve. The IDI is presented by Valuate Health Consultancy. Follow Valuate on LinkedIn or visit us at ValuateHealth.com to learn more.

Information

  • Creator
    Valuate Health Consultancy
  • Years Active
    2022 - 2024
  • Episodes
    26
  • Rating
    Clean
  • Show Website
    The IDI

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada